RVMD
NASDAQ · Biotechnology
Revolution Medicines Inc
$144.15
+2.34 (+1.65%)
Performance
1D
—
1W
—
1M
—
3M
+47.11%
6M
+123.90%
1Y
+244.20%
YTD
+82.42%
Open$142.56
Previous Close$141.81
Day High$145.52
Day Low$141.58
52W High$155.70
52W Low$34.00
Volume—
Avg Volume3.35M
Market Cap30.30B
P/E Ratio—
EPS$-4.80
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$94.85
Above
SMA 200
$58.23
Above
RSI (14)
62.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
-20.8% upside
Current
$144.15
$144.15
Target
$114.11
$114.11
$80.83
$114.11 avg
$120.13
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.27B | 6.60B | 6.07B |
| Net Income | 320.45M | 295.32M | 319.17M |
| Profit Margin | 4.4% | 4.5% | 5.3% |
| EBITDA | 413.26M | 366.06M | 402.03M |
| Free Cash Flow | 328.07M | 289.36M | 393.55M |
| Rev Growth | +0.4% | +7.5% | +13.8% |
| Debt/Equity | 0.86 | 0.80 | 0.86 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $202.78 | +0.61% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $329.59 | -0.64% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $133.52 | +1.67% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $435.17 | +1.24% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $712.77 | -0.30% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $284.84 | -3.46% | 130.4 | 40.90B |